Biopharmaceuticals: Definition and Regulation

doi 10.1002/9780470292549.ch1
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

John Wiley & Sons, Inc.

Related search

Editorial: Antibodies and Other Biopharmaceuticals

Biotechnology Journal
Applied MicrobiologyBiotechnologyMolecular MedicineMedicine
2008English

Structural Biological Approach to Biopharmaceuticals

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Insurance Coverage of Biopharmaceuticals

Health Affairs
MedicineHealth Policy
2006English

Supramolecular PEGylation of Biopharmaceuticals

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Seed Dormancy Back on Track; Its Definition and Regulation by DOG1

New Phytologist
Plant SciencePhysiology
2020English

Microbial Quality Concerns for Biopharmaceuticals

2012English

The Cost-Effectiveness of Biopharmaceuticals

mAbs
AllergyImmunology
2012English

Maintaining Consistent Quality and Clinical Performance of Biopharmaceuticals

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2018English

Multidimensional Methods for the Formulation of Biopharmaceuticals and Vaccines

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy